A Double-Blind Two Part Placebo-Controlled Study Consisting of a Single Ascending and Multiple-Dose Tolerance Study of Peroral Insulin in Patients With Type 2 Diabetes.
Phase of Trial: Phase I/II
Latest Information Update: 21 Jul 2011
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ORA2
- 04 Oct 2010 Status changed from recruiting to suspended as reported by ClinicalTrials.gov (NCT00990444).
- 12 Oct 2009 New trial record